Home > News > Interactive Q&A: Joe Cross, President and CEO of Nanophase Technologies
March 4th, 2008
Interactive Q&A: Joe Cross, President and CEO of Nanophase Technologies
Abstract:
This interactive Q&A is with Joe Cross, President and CEO of Nanophase Technologies (NASDAQ: NANX). Nanophase has sponsored this interview, which works like this:
* Joe briefly introduces himself and the issues he's focused on below.
* Readers and contributors can immediately start to post questions and remarks using the comment box below (free SA registration required).
* Seeking Alpha editors will not filter or edit the questions and comments from readers, except to delete profane or hostile language.
* Joe will respond to the questions and remarks beginning Monday, March 3rd. Readers can track his answers and respond to them during that period, with the resulting dialogue remaining on the site.
Readers from external sites may join the Q&A by following this link. seekingalpha.com/article/65806
Source:
seekingalpha.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||